University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 8 of 15
Exercise With Music for ICU Survivors
NCT03885687
CircaHealth Development and Evaluation
NCT03835572
Healthy Mothers-Healthy Children Nutrition
NCT03866902
Daily Undulating Periodization Methods With Parkinson's Disease
NCT03867877
Multidirectional Yoga for Cognition
NCT03799640
AvenovaTM as a Sterile Skin Preparation Agent
NCT02990013
Feasibility Study of a Nurse Intervention to Impact Mucositis Severity and Prevent Dehydration
NCT03416582
Viral Conjunctivitis Treatment Study
NCT03861728
Computer Assisted Family Intervention to Treat Self-Harm Disparities in Latinas and Sexual/Gender Minority Youth
NCT03709472
Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants
NCT03695900
BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases
NCT03318549
NAC for Head Trauma-induced Anosmia
NCT03680911
Combination Versus Laser Treatment Only
NCT03661697
Simplified Insulin Regimen for the Elderly
NCT03660553
Motivational Interviewing to Increase PrEP Uptake (MI-PrEP)
NCT03592719
Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer
NCT03435471
Autologous Regeneration of Tissue (ART) for Wound Healing
NCT03796988
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
NCT03367871
Oxygenation Instability and Maturation of Control of Breathing in Premature Infants
NCT03445689
Treatment Response to Xiaflex for Men With Peyronie's Disease
NCT03774264
Liraglutide Effects on Epicardial Fat Inflammatory Genes
NCT03260881
VLU Dressing Study
NCT03621592
Reverberation Effects on MED-EL Recipients
NCT03143296
Well-Being and Physical Activity Study
NCT03194854
Diagnosis of mTBI in a Community Setting
NCT03539848
Compuflo Instrument for Thoracic ES Identification
NCT03376256
Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
NCT03613493
Automated & Coached Web-based Programs to Improve and Strengthen Romantic Relationships
NCT03568565
Healthsnap on Epicardial Adipose Tissue Study
NCT03683888
Transitions of Care Stroke Disparity Study (TCSD-S)
NCT03452813
Postprandial Lipid Tracer and Exercise in Spinal Cord Injury
NCT03691532
Heart Failure Medication Adherence
NCT03402750
HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals
NCT03222817
Adhear Bone Conduction System
NCT03533686
Intracorporeal vs Extracorporeal Urinary Diversion After Robot Assisted Radical Cystectomy
NCT03469362
Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)
NCT03529799
Effective Fraction of Inspired Oxygen With Nasal Cannula in Premature Infants
NCT03431818
Mindfulness Training for Medical Personnel
NCT03514862
Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach
NCT03266965
Energetic Response to Feeding and Exercise in SCI
NCT03545867
Training and Parkinson's
NCT03434327
Effect of Exercise on Chocolate Addiction
NCT03356509
Individualized Piano Instruction (IPI) for Improving Cognition in Breast Cancer Survivors.
NCT05909813
Examining the Distal Gut Microbiome After Spinal Cord Injury
NCT03319225
Losartan and Inflammation in Cystic Fibrosis
NCT03206788
Research in Ethno-Medicine and Education (REMED)
NCT05907187
Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters
NCT03203681
Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure
NCT03212976
Mindfulness Training in U.S. Army Cohorts
NCT03310112
Health Gatherings - For Your Health After Cancer
NCT03344757
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Miami pipeline card: 721 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.